Alkermes
ALKS
$24.65
Share price
1.61%
Change (1 day)
-15.52%
Change (1 year)
Categories
Number of shares outstanding for Alkermes (ALKS)
Number of shares outstanding as of April 2024 : 166,607,000
According to Alkermes's latest financial reports and stock price the company's current number of shares outstanding is 166,607,000. At the end of 2023 the company had 166,607,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Alkermes from 2001 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.16 B | 1.38% |
| 2022 | 0.16 B | 1.55% |
| 2021 | 0.16 B | 1.68% |
| 2020 | 0.15 B | 0.95% |
| 2019 | 0.15 B | 1.5% |
| 2018 | 0.15 B | 0.95% |
| 2017 | 0.15 B | 1.13% |
| 2016 | 0.15 B | 1.21% |
| 2015 | 0.15 B | 2.35% |
| 2014 | 0.14 B | 7.92% |
| 2013 | 0.13 B | 3.03% |
| 2012 | 0.13 B | 1.87% |
| 2011 | 0.12 B | 35.54% |
| 2010 | 95.66 M | 0.93% |
| 2009 | 94.78 M | -0.56% |
| 2008 | 95.31 M | -6.28% |
| 2007 | 0.10 B | 0.8% |
| 2006 | 0.10 B | 10.26% |
| 2005 | 91.5 M | 1.47% |
| 2004 | 90.17 M | 1.31% |
| 2003 | 89.01 M | 38.2% |
| 2002 | 64.4 M | 0.8% |
| 2001 | 63.89 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 1,344.84% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | 1,137.64% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 3,289.41% | 🇺🇸 USA |
 Sanofi SNY | 2,507,200,000 | 1,404.86% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 2,057,000,000 | 1,134.64% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 1,759.47% | 🇬🇧 UK |
 Zogenix ZGNX | 55,340,700 | -66.78% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 1,242,000 | -99.25% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 572.84% | 🇮🇱 Israel |